You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Health Effects of CREON2000 in Asthmatic Children

    SBC: General Innovations and Goods, Inc.            Topic: NIAID

    DESCRIPTIONprovided by applicantThe purpose of this trial is to investigate the effectiveness of the CREONA for improving asthma control and preventing or reducing asthma events in children with mild to moderate allergic asthmaThe patented CREONA device is being developed as an environmental control intervention that will serve as an adjunctive treatment of asthmaThe compact energy efficient desig ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Health Effects of CREON2000 in Asthmatic Children

    SBC: General Innovations and Goods, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): The purpose of this trial is to investigate the effectiveness of the CREON2000A for improving asthma control and preventing or reducing asthma events in children with mild to moderate allergic asthma. The patented CREON2000A device is being developed as an environmental control intervention that will serve as an adjunctive treatment of asthma. The compact energ ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Multifunction High Throughput System for Neurophysiology of Behavior

    SBC: BIOGRAPHICS, INC.            Topic: 500

    DESCRIPTION provided by applicant The goal of this project is to create a system to conduct research with the assistance of a andapos High Throughput Multifunction System for Neurophysiology of Behaviorandapos This Phase II application to the Omnibus Solicitation is based on the Phase I for PA that was funded by NIAAA R AA The advanced system will provide capabilities for m ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Peptide-coated skin substitutes for the treatment of burn injuries and wounds

    SBC: AFFINERGY, LLC            Topic: 300

    DESCRIPTION provided by applicant Burn injuries and chronic wounds present a significant burden to patients and the US healthcare system Each year in the US there are burns that require medical treatment and burn patients that require hospitalization The mortality rate associated with severe burns can be as high as with of patient deaths arising from infection In add ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Phase-Cancelled, Broadband, Graphene-based Impedance Sensor

    SBC: Advratech            Topic: CBD14102

    An innovative phase-cancelled radio frequency/microwave graphene-based impedance chemical gas sensor has been demonstrated in Phase I with the record high sub-ppb sensitivity of NH3 and DMMP in air. Our sensor shows excellent selectivity for sensing NH3 and DMMP in a complex environment, and is capable of in-situ multiplexed sensing. In Phase II, the sensor will be fully integrated on a 3 glass wa ...

    SBIR Phase II 2014 Department of DefenseOffice for Chemical and Biological Defense
  6. Gene Expression Signatures to Predict Treatment Response in Systemic Sclerosis

    SBC: CELDARA MEDICAL, LLC            Topic: NIAMS

    DESCRIPTION provided by applicant Today systemic sclerosis SSc clinical trials generally include all subsets some may benefit others do not confounding measures of efficacy Because each expression subset has a different underlying deregulated molecular pathway no single drug is expected to benefit all patients i e rational patient selection is required to facilitate drug development F ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. See It Be It: Interactive Technology to Increase School Engagement and Prevent Dropout

    SBC: 3-C Institute for Social Development, Inc.            Topic: NIMHD

    DESCRIPTION provided by applicant Dropping out of school costs the nation up to $ billion annually in lost wages unemployment incarceration costs welfare dependence and health care costs Moreover poorer individual health and well being result from dropping out Despite recent reductions in the total number of dropouts minority students remain twice as likely to drop out as White stud ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease

    SBC: Immunext, Inc.            Topic: NIAID

    DESCRIPTION provided by applicant Systemic lupus erythematosus SLE is a devastating autoimmune disease that most commonly affects women in their child bearing years SLE attacks multiple organ systems but renal and neurologic involvement are the usual harbingers of poor outcome Despite effective albeit toxic immunosuppressive therapy only of patients with these serious manifestations ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Fluorolog: A Rapid-Acting Ultra-Concentrated Insulin Formulation

    SBC: THERMALIN DIABETES, INC.            Topic: 200

    DESCRIPTION provided by applicant In this Phase SBIR application we seek to advance toward human clinical trials a rapid acting and ultra concentrated monomeric insulin analog of novel halogen based protein design Designated Fluorolog this analog was found in Phase I studies to exhibit rapid acting PK PD properties irrespective of protein concentration in the range mM i e from ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Miniature Stimulator for Temporary Therapies

    SBC: SPR THERAPEUTICS, INC.            Topic: NICHD

    DESCRIPTION provided by applicant The goal of this project is to collect the safety and effectiveness clinical data necessary to commercialize the SMARTPATCH R system for post stroke shoulder pain PSSP The prevalence of stroke is approximately million in the US with additional persons surviving a stroke each year Moderate to severe shoulder pain develops in a quarter to a third ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government